ID   BLIN-2
AC   CVCL_QW48
SY   BLIN2; B-lineage 2
DR   Wikidata; Q54797359
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9808575;
CC   Characteristics: Requires bone marrow stromal cells or skin fibroblasts for optimal growth.
CC   Doubling time: ~2 days (PubMed=9808575).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=9808575; DOI=10.1182/blood.V92.10.3817;
RA   Shah, Nisha
RA   Oseth, LeAnn Louise
RA   LeBien, Tucker W.
RT   "Development of a model for evaluating the interaction between human
RT   pre-B acute lymphoblastic leukemic cells and the bone marrow stromal
RT   cell microenvironment.";
RL   Blood 92:3817-3828(1998).
//